Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global gelatin capsule market was valued at USD 2.11 billion in 2024. The market is projected to grow from USD 2.26 billion in 2025 to USD 3.34 billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.
Gelatin capsules are pharmaceutical dosage forms consisting of a gelatin shell that encloses active ingredients, such as powders, granules, or semisolids, to form a capsule. They are a preferred delivery system because they offer excellent bioavailability, are easy to swallow, and dissolve quickly and reliably in the stomach, ensuring consistent drug release. The two primary types are hard capsules, typically used for solid formulations, and softgels, which are often used for oils and active ingredients that are liquid at room temperature.
The market's steady expansion is largely driven by the robust growth of the global pharmaceutical industry and rising consumer preference for capsule-based dosage forms over tablets. Furthermore, the increasing demand for nutraceuticals and health supplements is a significant contributor. However, the market also faces challenges, such as the growing preference for vegetarian alternatives like HPMC capsules. Despite this, market leaders are actively investing in technological advancements to improve production efficiency and capsule performance. The market is moderately consolidated, with the top five players, including Capsugel (a Lonza company) and ACG, holding a combined market share of approximately 70%.
Growth in Pharmaceutical and Nutraceutical Industries
The global gelatin capsule market is primarily driven by the expanding pharmaceutical and nutraceutical sectors. The rising prevalence of chronic diseases necessitates increased drug consumption, with capsules being a preferred dosage form due to their ease of swallowing and accurate dosing. The nutraceutical boom, fueled by growing health consciousness, further propels demand for gelatin capsules for dietary supplements and vitamins.
Consumer Preference for Convenient Dosage Forms
There is a strong consumer inclination towards convenient and easy-to-administer drug formulations. Gelatin capsules mask unpleasant tastes and odors of active ingredients, improving patient compliance, especially among pediatric and geriatric populations. This preference is a significant factor driving market growth.
➤ The global nutraceuticals market is projected to grow at a CAGR of over 8%, directly boosting gelatin capsule consumption.
Furthermore, technological advancements in capsule manufacturing, such as the development of specialized capsules for targeted drug delivery, are creating new avenues for market expansion.
MARKET CHALLENGES
Rising Competition from Non-Animal Alternatives
A significant challenge facing the gelatin capsule market is the growing consumer demand for vegetarian and halal/kosher-certified products. This has led to increased competition from plant-based alternatives like HPMC (hydroxypropyl methylcellulose) capsules, which appeal to specific dietary and ethical preferences.
Other Challenges
Supply Chain and Raw Material Volatility
The market is susceptible to fluctuations in the supply and price of raw materials, primarily derived from animal by-products. Outbreaks of animal diseases can disrupt the supply chain, leading to price instability and potential shortages.
Regulatory Hurdles
Stringent regulatory requirements for quality control and safety, particularly concerning animal-origin materials, pose compliance challenges for manufacturers and can slow down product approvals.
Ethical and Religious Concerns
The animal-derived nature of gelatin is a major restraint, as it is not suitable for vegetarians, vegans, or individuals following specific religious dietary laws. This limits the potential consumer base and pushes some brands toward non-animal substitutes.
Limitations in Stability and Compatibility
Gelatin capsules have known limitations with certain hygroscopic or cross-linking formulations, which can affect the stability and bioavailability of the drug. This incompatibility restricts their use for a range of modern active pharmaceutical ingredients.
Expansion in Emerging Markets
Rapidly growing pharmaceutical markets in Asia-Pacific and Latin America present substantial opportunities. Increasing healthcare expenditure, improving access to medicines, and a rising middle class in these regions are expected to drive significant demand for gelatin capsules.
Innovation in Specialty Capsules
There is a growing opportunity for innovation in developing value-added gelatin capsules, such as enteric-coated capsules for delayed release, liquid-filled capsules for improved bioavailability, and capsules with unique branding and coloring for product differentiation.
The development of bovine-hide sourced gelatin, which addresses some religious concerns compared to porcine sources, also opens up new market segments.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Stomach-soluble Gelatin Capsules dominate the market, favored for their excellent bioavailability and rapid dissolution in gastric fluids, making them the preferred choice for a wide array of standard-release pharmaceutical formulations. Enterosoluble capsules serve a critical niche for drugs requiring targeted delivery to the intestines, protecting active ingredients from stomach acid. The consistent and reliable performance of these primary types has cemented their role as fundamental components in modern drug delivery systems. |
| By Application |
|
Pharmaceutical applications represent the most significant and demanding segment, driving the majority of market volume. This dominance is attributed to the capsule's critical function in ensuring precise dosage, enhancing patient compliance through ease of swallowing, and masking unpleasant tastes of active pharmaceutical ingredients. The healthcare products segment, including vitamins and supplements, leverages gelatin capsules for their consumer-friendly format, while other applications encompass specialized uses in areas like nutraceuticals, showcasing the versatility of the delivery system. |
| By End User |
|
Pharmaceutical Companies are the principal end users, relying heavily on gelatin capsules for their extensive drug portfolios and new product development pipelines. Their stringent quality control requirements and large-volume production needs create a stable, high-demand market. CMOs are a vital and growing segment, as many companies outsource capsule filling to benefit from specialized expertise and manufacturing efficiency. Nutraceutical companies utilize capsules to add value and convenience to their supplement offerings, driving consistent demand from the wellness sector. |
| By Functionality |
|
Immediate Release functionality is the standard and most widely adopted feature, as it meets the needs for quick drug absorption and onset of action for a majority of therapeutic compounds. Delayed and modified release capsules are essential for sophisticated drug delivery strategies, enabling targeted therapy, improved patient outcomes by maintaining consistent drug levels, and reduced dosing frequency. This segmentation highlights the industry's progression beyond basic encapsulation towards engineered solutions that enhance therapeutic efficacy. |
| By Source Material |
|
Bovine-sourced gelatin remains the traditional and most prevalent material, prized for its strong gelling properties and consistent performance in capsule manufacturing. Porcine-sourced gelatin is also a major contributor, though its use can be influenced by regional and cultural preferences. The Marine & Poultry segment is an important and growing category, driven by demand for alternative sources to address dietary restrictions, religious considerations, and the rising popularity of halal and kosher certified products, reflecting evolving consumer and regulatory landscapes. |
A Consolidated Market Led by Global Specialists
The global gelatin capsule market exhibits a consolidated structure, with the top five players collectively accounting for approximately 70% of the market share. Lonza Group AG (operating its capsule business as Capsugel) is the undisputed global leader, renowned for its extensive product portfolio, technological innovation, and significant production capacity. ACG and Qualicaps are other dominant multinational players, competing strongly on a global scale with a focus on pharmaceutical-grade quality and compliance. This high level of concentration is driven by stringent regulatory requirements, the capital-intensive nature of manufacturing, and the critical need for consistent, high-quality raw materials. These leading companies have established strong relationships with major pharmaceutical clients, creating significant barriers to entry for new players.
Beyond the major global leaders, the market includes several significant regional and specialized manufacturers that hold important niche positions. Companies like Suheung in South Korea and Farmacapsulas SA in Latin America are key players in their respective regions, catering to local and regional demand with competitive pricing and logistical advantages. In major manufacturing hubs like China, a number of companies such as Huangshan Capsule, Lefan Capsule, and MEIHUA Group have substantial production volumes, primarily serving the domestic and broader Asian markets. Other notable participants include Erawat Pharma Limited and Nectar Lifesciences Ltd. in India, and Roxlor, which focus on specific segments or customer needs, contributing to the overall diversity and competitive dynamics of the market.
List of Key Gelatin Capsule Companies ProfiledCapsugel (Lonza Group AG)
Suheung
ERAWAT PHARMA LIMITED
Dah Feng Capsule
Lefan Capsule
Shing Lih Fang
Roxlor
Nectar Lifesciences Ltd.
Kangke
Angtai
Qinhai Gelatin Company
MEIHUA Group
Yili Capsule
The global gelatin capsule market is on a definitive growth trajectory, with its valuation of $2,112 million in 2024 projected to surge to $3,339 million by 2031, representing a compound annual growth rate (CAGR) of 6.9%. This steady expansion is underpinned by the fundamental advantages of gelatin capsules, including their excellent bioavailability and the ability to dissolve quickly and reliably in the stomach. The market is characterized by a high level of consolidation, with the top five global players collectively holding approximately 70% of the market share, indicating a competitive landscape dominated by established, large-scale manufacturers.
Other TrendsGeographical Market Concentration
Market dominance is geographically concentrated, with Europe representing the largest single market, accounting for about 35% of the global share. This is closely followed by the combined markets of North America and Asia-Pacific, which together hold a substantial 55% share. This distribution highlights the strong demand for pharmaceutical and healthcare products in these developed and rapidly developing regions, driving consistent consumption of gelatin capsules for drug delivery systems.
Product and Application Segmentation Trends
The market is distinctly segmented by product type and application. Stomach-soluble gelatin capsules are the overwhelmingly dominant product category, commanding a share of approximately 75%. This preference is due to their suitability for a wide range of active pharmaceutical ingredients. In terms of application, the pharmaceutical industry is the largest end-user, leveraging capsules for a vast array of oral solid dosage forms. The healthcare products sector, which includes vitamins and supplements, represents the next significant application segment, fueled by growing consumer health consciousness.
Competitive Landscape and Industry FocusThe competitive environment features key players such as Lonza, Qualicaps, and ACG, who continue to focus on strategies to maintain and grow their market positions. The industry's focus remains on ensuring consistent quality, meeting stringent regulatory standards across different regions, and optimizing production capabilities to cater to the steadily increasing global demand. The analysis of market dynamics, including drivers, challenges, and potential risks, is crucial for stakeholders to navigate the opportunities within this growing market effectively.
Regional Analysis: Gelatin Capsule MarketNorth America
North America remains a highly significant and sophisticated market for gelatin capsules, characterized by stringent regulatory standards overseen by the FDA and Health Canada. The region's demand is driven by a well-established pharmaceutical industry with a strong focus on branded drugs, complex generics, and high-value clinical trial materials. There is a notable trend towards specialty capsules, including those with modified release properties and capsules developed for highly potent active pharmaceutical ingredients (APIs), requiring advanced manufacturing capabilities. The market also sees steady demand from the robust nutraceutical and cosmeceutical sectors. While manufacturing costs are higher compared to Asia-Pacific, the region excels in innovation, quality control, and serving niche, high-margin segments of the market.
Europe
Europe represents a mature yet stable market for gelatin capsules, with demand closely tied to its large and innovative pharmaceutical sector, particularly in Germany, France, and Switzerland. The market is characterized by a high degree of regulatory scrutiny from the EMA, emphasizing quality, safety, and traceability, especially concerning bovine spongiform encephalopathy (BSE)/TSE compliance for animal-derived gelatin. There is growing consumer and manufacturer interest in plant-based alternatives, but gelatin capsules continue to hold a dominant share due to their excellent technical properties and established supply chains. Demand is sustained by both prescription pharmaceuticals and a well-developed market for over-the-counter drugs and health supplements, with manufacturers focusing on value-added features and sustainable sourcing practices.
South America
The gelatin capsule market in South America is experiencing steady growth, fueled by an expanding pharmaceutical industry and improving healthcare access in countries like Brazil and Argentina. The region benefits from its own substantial livestock industry, which provides a local source for raw materials, reducing import dependence. Market dynamics are influenced by economic fluctuations and government healthcare policies, but the essential nature of pharmaceuticals ensures a consistent baseline demand. Local manufacturers are increasingly investing in capacity and technology to meet domestic needs and explore export opportunities, though the market remains largely focused on standard capsule formats for generic medicines and essential vitamins.
Middle East & Africa
The Middle East and Africa region presents a market with diverse and evolving dynamics for gelatin capsules. The Gulf Cooperation Council (GCC) countries, with their high per capita healthcare expenditure, represent a more developed market segment, often importing high-quality capsules for local pharmaceutical production and repackaging. In contrast, many African nations are characterized by a growing population and increasing efforts to improve healthcare infrastructure, which is gradually driving demand for essential medicines, often supplied in capsule form. The market faces challenges related to supply chain reliability and economic variability, but it is viewed as a region with significant long-term growth potential, especially as local manufacturing capabilities begin to develop.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2031. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global gelatin capsule market was valued at USD 2.11 billion in 2024 and is expected to reach USD 3.34 billion by 2031.
-> Key players include Capsugel (Lonza), Qualicaps, ACG, Suheung, and Farmacapsulas SA, among others.
-> The market is projected to grow at a CAGR of 6.9% during the forecast period.
-> Europe is the largest market with approximately 35% share, followed by North America and Asia-Pacific.
-> The largest application segment is Pharmaceutical, followed by Healthcare Products.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates